COMPANY PROFILE / #306
Formation Bio
Developer of a biotech investment and development platform intended to accelerate drug development. The company's platform utilizes AI-driven technologies, customized workflow enhancements, strategic acquisition of clinical-stage assets, adaptable licensing structures, and integrated expert teams, enabling pharma partners and research institutions to advance treatments more efficiently while reducing cost, time, and development risk.Privately Held (backing)
已融资150
最新估值—
员工数—
成立年份Xaira Therapeutics, InSilico Medicine Cayman, EQRx, Enveda, Profluent, CTI Clinical Trial and Consulting
公司概况
- Companies
- Formation Bio
- Description
- —
- Website
- New York, NY
- HQ Location
- Developer of a biotech investment and development platform intended to accelerate drug development. The company's platform utilizes AI-driven technologies, customized workflow enhancements, strategic acquisition of clinical-stage assets, adaptable licensing structures, and integrated expert teams, enabling pharma partners and research institutions to advance treatments more efficiently while reducing cost, time, and development risk.
- Year Founded
- Xaira Therapeutics, InSilico Medicine Cayman, EQRx, Enveda, Profluent, CTI Clinical Trial and Consulting
- Keywords
- 2026: 150, 2025: 180, 2024: 165, 2023: 160, 2022: 110, 2021: 105, 2020: 103, 2019: 157
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 150
- First Financing Date
- 0.50
- First Financing Size
- 13
- First Financing Valuation
- ben.liu@trialspark.com
- Last Financing Date
- -0.03%
- Last Financing Deal Type
- 26-Jun-2024
- Last Financing Size
- Later Stage VC
- Last Financing Valuation
- —
- Last Financing Status
- 1,700.00
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- 0.03
- Valuation Estimate
- 26-Jun-2024
- Valuation Estimate Growth Rate
- academic medical center, ai in healthcare, ai medical platform, biotechnology research, clinical trial sites, clinical workflow automation, licensing model, medical research, pharmaceutical innovations, scientific research
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 12%
- Acquirers
- 3cubed Ventures, AlphaLab, Andreessen Horowitz, ArrowMark Partners, Bridgespan VC, Casdin Capital, Cherubic Ventures, Dragoneer Investment Group, Emerson Collective, Felicis, FPV Ventures, Innovation Works, John Doerr, Lachy Groom, LTS Growth, Mantis VC, Michael Moritz, Northstar.VC, PureTech Health, S32, Samuel Altman, Sanofi, Sequoia Capital, Sound Ventures, Spark Capital, SV Angel, Thrive Capital, TQ Ventures
团队与联系人
- Employees
- —
- Employee Growth %
- 2013
- Employee History
- —
- Primary Contact
- 618.82
- Primary Contact Title
- —
- Primary Contact Email
- Benjamine Liu
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 11.95%
- Growth Rate
- 3.68%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 562
- Size Multiple
- —
- Size Multiple % Change
- 1,700.00
- Size Multiple Change
- 0.03%
- Size Multiple Percentile
- 0.01x
- Majestic Referring Domains
- 28.85x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- 01-Jan-2016
- SimilarWeb Growth Rate
- 97
- SimilarWeb Growth Rate Percentile
- 6,512
- Success Probability Over Time – 1 Year
- 27%
- Success Probability Over Time – 3 Year
- 44%
- Success Probability Over Time – 5 Year
- Co-Founder & Chief Executive Officer
记录来源：public.companies · 原始序号 #306 · 所有字段均按数据库原值展示。